Han, L.; Ye, G.; Su, W.; Zhu, Y.; Wu, W.; Hao, L.; Gao, J.; Li, Z.; Liu, F.; Duan, J.
Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway. Biomolecules 2024, 14, 592.
https://doi.org/10.3390/biom14050592
AMA Style
Han L, Ye G, Su W, Zhu Y, Wu W, Hao L, Gao J, Li Z, Liu F, Duan J.
Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway. Biomolecules. 2024; 14(5):592.
https://doi.org/10.3390/biom14050592
Chicago/Turabian Style
Han, Li, Guoxin Ye, Wenjing Su, Yuankang Zhu, Wenqi Wu, Liangshi Hao, Jing Gao, Zhen Li, Fang Liu, and Junli Duan.
2024. "Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway" Biomolecules 14, no. 5: 592.
https://doi.org/10.3390/biom14050592
APA Style
Han, L., Ye, G., Su, W., Zhu, Y., Wu, W., Hao, L., Gao, J., Li, Z., Liu, F., & Duan, J.
(2024). Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway. Biomolecules, 14(5), 592.
https://doi.org/10.3390/biom14050592